Health enhancing physical activity in all policies? Comparison of national public actors between France and Belgium.


Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
03 2019
Historique:
received: 17 10 2017
revised: 31 10 2018
accepted: 12 01 2019
pubmed: 5 2 2019
medline: 16 7 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

Despite evidence on the benefits of health enhancing physical activity (HEPA), only few countries have developed "health in all policies" and specifically integrated HEPA policies. Paucity of studies have questioned the role of public national actors in PA policies enactment and delivery, the barriers and levers for adopting cross-sectoral HEPA. The present work seeks at comparing France and Belgium in regard to their competencies of ministries promoting HEPA, the presence of leadership and coordination in HEPA policies implementation, their key public legal entities working on HEPA. Expert interviews and document analysis were realized to complete the HEPA policy audit tool in each country. Results have shown that HEPA cross-sectoral policies are at their early stage. A broad diversity of sectors was implicated in HEPA policies: sport, health, transport, environment, and education, but often with weak activity. No leadership or coordination exist to implement HEPA policies, although different public legal entities could work on this aim. Ministries relationships were principally coming from formal co-interventions mandated by national public plans in France, where in Belgium relationships were punctual. Lobbying within each sector and in key public legal entities to promote HEPA is needed, and the development of official national coordination is essential.

Identifiants

pubmed: 30712920
pii: S0168-8510(19)30019-3
doi: 10.1016/j.healthpol.2019.01.008
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

327-332

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Aurélie Van Hoye (A)

Université de Lorraine, EA4360 APEMAC, 54000 Nancy, France. Electronic address: aurelie.van-hoye@univ-lorraine.fr.

Chantal Vandoorne (C)

Université de Liège, APES-ULiège, 4000 Liège, Belgium.

Gaetan Absil (G)

Université de Liège, APES-ULiège, 4000 Liège, Belgium.

Flore Lecomte (F)

Société française de santé publique, 54520 Laxou, France.

Catherine Fallon (C)

Université de Liège, SPIRAL, 4000 Liège, Belgium.

Pierre Lombrail (P)

Université Paris 13, EA 3412 LEPS, 93017 Bobigny, France.

Anne Vuillemin (A)

Université Côte d'Azur, LAMHESS, 06205 Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH